20 Oct 2015: Guerrero NA, Camacho M, Vila L, Íñiguez MA, Chillón-Marinas C, et al. (2015) Correction: Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection. PLOS Neglected Tropical Diseases 9(10): e0004175. doi: 10.1371/journal.pntd.0004175 View correction
Inflammation plays an important role in the pathophysiology of Chagas disease, caused by Trypanosoma cruzi. Prostanoids are regulators of homeostasis and inflammation and are produced mainly by myeloid cells, being cyclooxygenases, COX-1 and COX-2, the key enzymes in their biosynthesis from arachidonic acid (AA). Here, we have investigated the expression of enzymes involved in AA metabolism during T. cruzi infection. Our results show an increase in the expression of several of these enzymes in acute T. cruzi infected heart. Interestingly, COX-2 was expressed by CD68+ myeloid heart-infiltrating cells. In addition, infiltrating myeloid CD11b+Ly6G- cells purified from infected heart tissue express COX-2 and produce prostaglandin E2 (PGE2) ex vivo. T. cruzi infections in COX-2 or PGE2-dependent prostaglandin receptor EP-2 deficient mice indicate that both, COX-2 and EP-2 signaling contribute significantly to the heart leukocyte infiltration and to the release of chemokines and inflammatory cytokines in the heart of T. cruzi infected mice. In conclusion, COX-2 plays a detrimental role in acute Chagas disease myocarditis and points to COX-2 as a potential target for immune intervention.
The role of prostanoids, products of the arachidonic acid pathway, during Trypanosoma cruzi infection has been studied by inhibiting key enzymes in prostanoid synthesis as cyclooxygenases (COX-1 and COX-2), with opposed results. Here we analyzed the expression of cyclooxygenases, prostanoid synthases and receptors in the heart of mice susceptible and non-susceptible to T. cruzi infection and found that they were highly increased respect to non-infected mice. We previously identified the presence of myeloid-derived suppressor cells expressing arginase-1 (Arg-1). Further analysis showed that COX-2 was expressed in Arg-1- myeloid cells in heart tissue, suggesting the existence of different myeloid populations involved in the leukocyte infiltration (COX-2+Arg-1-) and tissue repair (COX-2-Arg-1+). Mice deficient in the expression of COX-2 and the prostaglandin PGE2 receptor EP-2 infected with T. cruzi showed a marked reduction in the cardiac inflammatory infiltration in comparison with infected wild type mice, indicating an adverse effect of COX-2 and PGE2 signaling through EP-2 receptor in the development of myocarditis during acute T. cruzi infection, suggesting the possibility of immune intervention using COX inhibitors.
Citation: Guerrero NA, Camacho M, Vila L, Íñiguez MA, Chillón-Marinas C, Cuervo H, et al. (2015) Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection. PLoS Negl Trop Dis 9(8): e0004025. doi:10.1371/journal.pntd.0004025
Editor: Herbert B. Tanowitz, Albert Einstein College of Medicine, UNITED STATES
Received: March 10, 2015; Accepted: August 2, 2015; Published: August 25, 2015
Copyright: © 2015 Guerrero et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This work was supported by (NG) grants from “Fondo de Investigaciones Sanitarias” (PS09/00538 and PI12/00289); “Universidad Autónoma de Madrid” and “Comunidad de Madrid” (CC08-UAM/SAL-4440/08); by (MF) grants from “Ministerio de Ciencia e Innovación” (SAF2010-17833); “Red de Investigación de Centros de Enfermedades Tropicales” (RICET RD12/0018/0004); European Union (HEALTH-FE-2008-22303, ChagasEpiNet); AECID Cooperation with Argentine (A/025417/09 and A/031735/10), Comunidad de Madrid (S-2010/BMD-2332) and “Fundación Ramón Areces”. NAG was recipient of a ISCIII Ph.D. fellowship financed by the Spanish “Ministerio de Sanidad”. CCM and HC were recipients of contracts from SAF2010-17833 and PI060388, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Chagas disease is a multisystemic disorder caused by Trypanosoma cruzi infection that affects more than 8 million people worldwide, being endemic in Latin America. Due to the scarcity of preventive and therapeutic tools and population at risk, it is considered as a neglected tropical disease [1, 2]. More than 40,000 new infected people and 12,550 deaths per year are estimated. The high rate of migration towards non-endemic countries has spread the boundaries of the infection to other continents. Non-vectorial transmission is possible through oral ingestion, blood transfusion, organ transplantation and during pregnancy. The risk of infection is related to the country of origin of the migrants and the rate of prevalence in a given country .
Chagas disease is characterized by acute and chronic phases. Death occurs occasionally in the acute phase (<5–10% of symptomatic cases) as a result of severe myocarditis, meningoencephalitis, or both. The experimental model of infection in mice recapitulates many clinical features observed in human infection, although different strains of mice and parasites produce different disease outcomes .
Heart inflammation during the acute phase of T. cruzi experimental infection is initiated by lymphoid and myeloid mononuclear cell infiltration . We have isolated from infected hearts an infiltrating monocytic CD11b+Ly6C+Ly6G- population expressing both classical (M1) and alternatively (M2) activated macrophage markers that is able to suppress T cell proliferation ex vivo, characteristics that define them as myeloid-derived suppressor cells (MDSCs) [6, 7].
Myeloid cells are thought to be the major source of prostanoids, end products of cell membrane arachidonic acid (AA) catabolism, which include prostaglandins, prostacyclin and thromboxanes . Enzymes implicated in prostanoid production have been investigated for many years . All these lipid mediators have important roles in homeostasis and immune response regulation . Cyclooxygenases, COX-1 and COX-2, are principal enzymes in prostanoid production. COX-1 expression is involved in homeostasis while COX-2 is induced by several factors, including infection . However, the specific role of COX-2 and downstream enzymes in the context of infection varies depending on the infectious agent [11–13].
PGE2, a product of terminal PGE2 synthases (PGES) has pro-inflammatory properties  but also immunosuppressive properties  by signaling through G-protein coupled PGE receptors (EP), termed EP-1, EP-2, EP-3 and EP-4. PGE2 also decreases the ability of macrophages to phagocytize and kill microorganisms [16, 17], and is required for monocyte migration in response to chemokines [18, 19].
There are few studies about the role of prostanoids in human chagasic pathology [20, 21], but it has been described that monocyte inflammatory mediators inhibit cellular proliferation and enhance cytokine production in patients . In rodent models of acute infection, the levels of PGF2α, TXB2, 6-oxo-PGF1α  and PGE2  in plasma, were increased. Macrophages from infected rats show an increased number of lipid bodies, where COX-2 produces PGE2 . Recently, it has been shown that the absence of Phospholipase A2γ, an enzyme implicated in AA release from membranes, decreases mice survival .
The role of COX in mice infected with T. cruzi has been studied using non-selective inhibitors of COX-1 and COX-2, as well as COX-2-selective inhibitors (NSAIDs), with conflicting results. Thus, it has been described that COX inhibitors cause an increase in mortality and parasitism  in T. cruzi infection, but contrarily, other reports claim that COX-2 inhibition decreases the level of parasitism [28, 29]. In addition, both beneficial and adverse effects of COX inhibitors have been reported, depending on the phase of T. cruzi infection and the mice strain used . Discrepancies between these studies could be explained by the different ability of BALB/c and C57BL/6 mouse strains to produce PGE2 ; the presence of distinct levels of cytokines in serum  or because of differences in cardiac cytokine expression profile .
Thus, in order to clarify the role of prostanoids in acute cardiac inflammation, we infected susceptible and non-susceptible mice, as well as COX-2 and EP-2 deficient mice with T. cruzi and analyzed cardiac inflammation, leukocyte infiltration and expression of cytokines, chemokines and inflammatory mediators in the infected mice.
Prostanoid-synthesizing enzymes in the heart tissue of T. cruzi infected mice
We infected mice with the Y strain of T. cruzi. Immunopathology caused by this parasite strain is characterized by cardiac inflammatory damage. As we previously reported , C57BL/6, but not BALB/c, infected mice recovered from infection and survived (S1A Fig). Parasitemia was detectable between 9 and 21 d.p.i. and was higher in BALB/c mice (S1B Fig). Hearts of BALB/c infected mice showed more leukocyte infiltration and parasite nests than C57BL/6 mice (S1C Fig). We next studied the expression level of enzymes involved in the AA pathway in the heart of both strains after infection (Fig 1A). COX-2 gene expression (Ptgs2), but not COX-1 (Ptgs1), was increased in heart tissue during the acute phase of T. cruzi infection similarly in both mouse strains. Ptges (microsomal prostaglandin E2 synthase, mPGES-1), Hpgds (leucocyte type PGD synthase) and Tbxas1 (thromboxane synthase) mRNA expression levels were also incremented. However, Ptgds (lipocalin-type prostaglandin D synthase) mRNA basal level of expression in heart tissue did not change upon T. cruzi infection. These results indicate that T. cruzi infection promoted the selective up-regulation of some of the enzymes involved in prostanoid production in heart tissue, including COX-2 and mPGES-1.
(A) Expression of Ptgs1, Ptgs2, Ptges (mPGES1), Ptgds, Hpgds and Tbxas1 in heart tissue of, either non-infected (0) or at different d.p.i. (7 to 28), BALB/c and C57BL/6 mice. Means ± SEM from three independent experiments (n = 9) are shown. Statistical comparisons are indicated * p< 0.05, *** p< 0.001. (B) Heart tissue samples from C57BL/6 mice at 14 d.p.i. and (C) BALB/c mice at 21 d.p.i., were stained with DAPI for nuclei (Blue) and specific antibodies for the macrophage marker CD68 (green) and the enzyme COX-2 (red). (D) Heart tissue from BALB/c mice at 21 d.p.i. stained for COX-2 (red), CD68 (green) and Arg-1 (magenta). In the merge of B, C and D, red, yellow and white arrows point to COX-2+, CD68+COX-2+ and CD68+Arg-1+ cells, respectively. Pictures are representative of several sections analyzed in 3 different mice from three independent experiments; the scale bar is 20 μm.
Myeloid cells in inflamed cardiac tissue express COX-2
Since COX-2 plays a key role in the synthesis of PGs in inflammatory processes, we aimed to identify the cells expressing this enzyme in the heart of T cruzi infected mice. Hearts from C57BL/6 (Fig 1B) and BALB/c (Fig 1C) mice were immunostained for COX-2 and myeloid and lymphoid markers, and imaged by confocal microscopy. Cells expressing COX-2 were abundant in the infected hearts of both mice strains, showing a strong staining in the perinuclear region of both myeloid CD68 positive and non-myeloid CD68 negative infiltrating cells. Interestingly, there was no co-localization of COX-2 and Arg-1, a marker of M2 macrophages and MDSCs (Fig 1D). Although COX-2 expression by activated lymphocytes has been previously described , CD4 staining was not detected in infiltrating COX-2+ cells in hearts of infected C57BL/6 (S2A Fig) nor BALB/c mice (S2C Fig). No staining was observed in negative control sections incubated with secondary antibodies alone (S2B, S2D and S2E Fig).
We next isolated myeloid cells from hearts of T. cruzi infected C57BL/6 and BALB/c mice at the times,14 and 21 d.p.i. respectively, when maximum Arg-1 and inducible nitric oxide synthase (iNOS) expression is observed . Using anti-Ly6G antibody labeled magnetic microbeads we obtained the Ly6G+ population. CD11b+ cells were selected from the remaining Ly6G- population, (Fig 2A). As previously described , the CD11b+Ly6G- cell population expressed iNOS and Arg-1, and here we show that they also expressed COX-2 (Fig 2A). Interestingly, COX-2 gene expression was much higher in CD11b+ cells obtained from infected cardiac tissue than those from the blood (Fig 2B), pointing to infiltrating myeloid cells in inflamed tissue as the source of COX-2.
(A) Purified Ly6G+, Ly6G-CD11b+and Ly6G-CD11b- cells were obtained from infected C57BL/6 (14 d.p.i.) and BALB/c (21 d.p.i.) mice hearts, by magnetic cell separation. Arg-1, iNOS and COX-2 levels were analyzed by Western blot. Protein levels of Actin are shown as loading control. A representative experiment of the two performed is shown. (B) CD11b+ cells were obtained from pooled infected BALB/c mouse hearts or blood at 21 d.p.i (n = 15). Ptgs2 (COX-2) expression in blood and heart tissue was determined by real time qRT-PCR. Mean ± SEM of two independent experiments is shown. (C) PGE2 and 6-oxo-PGF1α levels in total heart extracts of BALB/c from non-infected (0 d.p.i.) and 21 d.p.i., were determined as described in Methods and represented as scaled imputed data (ScaledImpData) after normalizing raw data values respect to median values of each day run (*p<0.05). Prostanoid production in purified Ly6G+ (D) and Ly6G- CD11b+ (E) cells from BALB/c mice hearts at 21 d.p.i. was determined by incubation with labeled 25 μM [C14] AA and analysis by HPLC (black line and text). Prostanoid standards (red line and text) were run in parallel as described in Methods. A representative experiment out of two performed is shown.
CD11b+Ly6G- cells from infected cardiac tissue produce PGE2
In agreement with the increase in COX-2 expression, a significant increase in the production of prostanoids as PGE2 and 6-oxo PGF1α in infected hearts was detected by mass spectrometry analysis on total heart extracts (Fig 2C). Further ex vivo analysis on Ly6G+ and CD11b+Ly6G- purified heart infiltrating myeloid cells cultured in the presence of radiolabeled AA, showed that Ly6G+ cells did not produce any detectable prostanoid (Fig 2D). In contrast, CD11b+Ly6G- cells produced high levels of PGE2 and low amounts of PGF2α (Fig 2E). These results indicate that the CD11b+Ly6G- myeloid population is able to synthesize high levels of PGE2 from AA, while other cell types in heart tissue are likely producing PGE2 and 6-oxo PGF1α.
Cardiac inflammation is reduced in COX-2-/- mice
In order to study the role of COX-2 in the development of cardiac leukocyte infiltration, we infected COX-2+/+ and COX-2-/- mice with the Y strain of the parasite. COX-2-/- mice showed 30% reduction in blood parasite number compared to COX-2+/+ mice at the peak of parasitemia (Fig 3A). However, COX-2 deficiency did not significantly affect cardiac parasite burden compared to COX-2+/+ infected mice (Fig 3B). No mortality was observed neither in COX-2+/+ nor in COX-2-/- infected mice up to 42 d.p.i.
(A) The presence of parasites in the blood of COX-2+/+ or COX-2-/- mice at different d.p.i. was quantified by direct counting under optical microscopy. (B) DNA from heart tissue was isolated and qPCR using T. cruzi DNA standard was performed to determine parasite burden in COX-2+/+ or COX-2-/- infected mice at 14 d.p.i. Means ± SEM from three independent experiments are shown (n = 4). (C) Heart tissue sections of COX-2+/+ and COX-2-/- mice either non-infected (0 d.p.i.) or 14 d.p.i., were stained with Masson’s Trichrome and inflammatory cell infiltration was quantified as described in Methods. (D) Representative pictures of heart tissue sections described in C. Arrows indicate inflammatory infiltration. Scale bar is 100 μm. (ns = non-significant; *p<0.05; **p< 0.01; ***p<0.001).
Inflammatory infiltrates were analyzed and quantified in T. cruzi infected hearts from COX-2+/+ and COX-2-/- mice. Fig 3C shows the extent of leukocyte infiltration calculated from several tissue sections as described in Methods. We observed significant less inflammatory infiltration in infected COX-2-/- than in COX-2+/+ mice. Representative images corresponding to the quantification of cell infiltration are shown in Fig 3D.
We next analyzed the cellular composition of the immune inflammatory infiltrate by determining gene expression of surface markers characteristic of various immune cell populations by qRT-PCR and normalizing the data from infected animals respect to non-infected controls. In agreement with histological findings, infection in COX-2-/- mice compared to COX-2+/+ mice, led to lower expression of the common leukocyte marker Ptprc (CD45) as well as of Cd4, Cd8, Cd68, and Itgax (CD11c) as markers of T helper cells, cytotoxic T cells, macrophages and dendritic cells, respectively (Fig 4A).
mRNA levels of the different genes analyzed was determined by qRT-PCR in heart tissue RNA samples isolated from non-infected (0 d.p.i.) or 14 d.p.i. COX-2+/+ or COX-2-/- mice. Data are expressed as RQ calculated from CT values as described in Methods. Gene expression of lymphoid and myeloid cell markers as Ptprc, Cd4, Cd8a, Cd68 and Itgax (A), chemokines as Ccl2, Ccl5 and Cxcl9 (B), cytokines as Ifng, Tnf, Il4, Il6 and Il10 (C) and enzymes as Arg1, Nos2, Ptgs1 and Ptges (mPGES1) (D) is shown. Means ± SEM from one representative experiment (n = 3) out of four is shown (n = 5; * p<0.05; **p<0.01; ***p<0.001).
To characterize the immune response in hearts of COX-2-/- infected mice, gene expression of chemokines and cytokines were analyzed. mRNA levels of chemokines (Ccl2, Ccl5 and Cxcl9) and cytokines (Ifng, Tnf, Il4, Il6 and Il10) were significantly increased during T. cruzi infection in hearts of both COX-2+/+ and COX-2-/- mice (Fig 4B and 4C). However, chemokine expression presented different patterns in COX-2+/+ and COX-2-/- mice. Ccl2 and Ccl5 expression, but not Cxcl9, was significantly higher in COX-2+/+ mice than in COX-2-/- mice (Fig 4B). Induction of pro-inflammatory cytokines Ifng, Tnf and Il6 was lower, whereas Il4 expression was higher, in COX-2-/- compared to COX-2+/+ mice (Fig 4C). The anti-inflammatory cytokine Il10 showed lower expression in the COX-2-/- infected mice. There were no significant differences in Arg1 expression between COX-2+/+ or COX-2-/- mice (Fig 4D), but induction of Nos2 mRNA (iNOS) was significantly lower in COX-2-/- infected mice (Fig 4D). There was no induction of Ptgs1 (COX-1) expression that could compensate for the COX-2-/- deficiency (Fig 4D). Ptges (mPGES-1) expression was increased upon infection, with lower levels in heart tissue from COX-2-/- mice compared to COX-2+/+ mice (Fig 4D). Nevertheless, protein analysis by western blot showed lower expression of both iNOS and Arg-1 in infected COX-2-/- respect to COX-2+/+ mice (Fig 5). Analysis of TNF-α levels in plasma showed a similar increase in both COX-2+/+ and COX-2-/- infected mice, indicating that the effect of COX-2 deficiency is not systemic but specific of the heart (S3A Fig). Basal levels of gene expression did not significantly change between COX-2+/+ and COX-2-/- mice (S4 Fig).
(A) Western blot analysis of iNOS and Arg-1 protein in extracts from hearts of COX-2+/+ and COX-2-/- from non-infected mice (0 d.p.i.) and at 14 d.p.i. Ponceau staining of the blot is shown as a loading control. Samples for 6 different infected mice are shown. (B) Quantification of iNOS and Arg-1 band areas relative to the Ponceau staining from COX-2+/+ (dashed black bars) and COX-2-/- (dashed gray bars) is represented as means ± SEM in arbitrary units. A representative experiment (n = 5) out of two is shown (**p<0.01).
Cardiac inflammation is reduced in EP-2-/- mice
We found increased levels of PGE2 in heart tissue and cardiac infiltrating cells after T. cruzi infection. Since the effector function of PGE2 produced by myeloid cells depends on its binding to EP receptors, we studied gene expression of its 4 receptors, EP-1 (Ptger1), EP-2 (Ptger2), EP-3 (Ptger3) and EP-4 (Ptger4), in hearts of mice during infection. The results show that in control infected mice the overall expression of EP receptors is higher than in non-infected hearts, except for Ptger3 (Fig 6A). However, in C57BL/6 infected hearts Ptger2 expression showed the highest increases suggesting a potential role of this receptor in T.cruzi infection. Thus, we used mice deficient in the expression of the EP-2 (in the C57BL/6 background), which has been involved in inflammation , and also in an autocrine loop of macrophage activation by PGE2 , in order to study the role of this receptor during T. cruzi infection. The results show that EP-2+/+ and EP-2-/- mice survived infection and no significant differences in parasitemia or in heart parasite burden were observed between them (Fig 6B and 6C). These results suggest that EP-2 signaling does not play an essential role in parasite elimination.
(A) mRNA levels of EP receptors (Ptger1, Ptger2, Ptger3 and Ptger4) was determined by qRT-PCR in heart tissue RNA samples isolated from C57BL/6 mice non-infected (0 d.p.i.) and at 14 days post-infection (n = 5). (B) The presence of the parasites in the blood of EP-2+/+ or EP-2-/- mice at different d.p.i. was quantified by direct counting under optical microscopy. (C) DNA from heart tissue was isolated and qPCR using T. cruzi DNA standard was performed to determine parasite burden in EP-2+/+ or EP-2-/- infected mice at 14 d.p.i. Means ± SEM from a representative experiment (n = 4) from three independent experiments are shown (n = 4). (D) Heart tissue sections of EP-2+/+ and EP-2-/- from non-infected mice (0 d.p.i.) and at 14 d.p.i., were stained with Masson’s Trichrome and inflammatory cell infiltration was quantified as described in Methods. (***p<0.001). (E) Representative pictures of heart sections described in C. Arrows indicate inflammatory infiltration. Scale bar is 100 μm.
However, significant less heart inflammatory infiltrates were observed in infected EP-2-/- in comparison with EP-2+/+ mice at 14 d.p.i. (Fig 6D). Representative images of cardiac tissue and inflammatory infiltration are shown in Fig 6E. The expression of the common leukocyte marker Ptprc (CD45) was lower in the heart of infected EP-2-/- mice respect to EP-2+/+, whereas mRNA levels of cell markers as Cd4 (Th cells), Cd8 (Tc cells), and Itgax- (CD11c; DCs), did not show significant differences. However, the expression of Cd68, a macrophage marker, significantly increased in EP-2-/- respect to EP-2+/+ mice (Fig 7A). Regarding chemokines, Ccl2 expression, but not Ccl5 and Cxcl9, was significantly reduced in the EP-2-/- compared to EP-2+/+ infected mice (Fig 7B). Induction of pro-inflammatory cytokines Ifng and Il6, the Th2 cytokine Il4 and the anti-inflammatory cytokine Il10, but not Tnf, was lower in EP-2-/- compared with EP-2+/+ (Fig 7C). Similarly to COX-2-/-, no differences were observed in TNF-α plasma levels in EP-2-/- as compared to EP-2+/+ infected mice (S3B Fig). Ptgs2 (COX-2) gene expression was significantly lower in EP-2-/- infected mice (Fig 7D). There were no differences between mouse strains in Nos2 mRNA (iNOS) expression (Fig 7D), but Arg1 mRNA expression was higher in EP-2-/- mice (Fig 7D). Western blot analysis showed a significant increase in EP-2-/- respect to EP-2+/+ mice, in the protein levels of these enzymes involved in L-arginine metabolism (Fig 8). Basal levels of gene expression did not significantly change between EP-2+/+ and EP-2-/- mice (S5 Fig).
Expression of the different genes was analyzed by qRT-PCR in RNA samples of heart tissue isolated from EP-2+/+ and EP-2-/- non-infected mice (0 d.p.i.) and at 14 d.p.i. Data are expressed as RQ calculated from CT values as described in Methods. Gene expression of lymphoid and myeloid cell markers as Ptprc, Cd4, Cd8a, Cd68 and Itgax (A), chemokines as Ccl2, Ccl5 and Cxcl9 (B), cytokines as Ifng, Tnf, Il4, Il6 and Il10 (C) and enzymes as Nos2, Ptgs2 and Arg1 (D) is shown. Means ± SEM from a representative experiment (n = 3) out of two is shown (n = 4;* p<0.05; **p<0.01; ***p<0.001).
(A) Western blot analysis of iNOS and Arg-1 protein in extracts from hearts of EP-2+/+ and EP-2-/- non-infected mice (0 d.p.i.) and at 14 d.p.i. Ponceau staining of the blot is shown as a loading control. Extracts from 3 different infected mice were loaded. (B) Quantification of iNOS and Arg-1 band areas relative to the Ponceau staining from EP-2+/+ (black bars) and EP-2-/- (gray bars) is represented as means ± SEM in arbitrary units. A representative experiment out of two is shown (**p<0.01; ***p<0.001).
Parasites and mice
BALB/c and C57BL/6 mice (6 to 8-week-old) were purchased from Harlan, Interfauna Iberica. B6;129S7-Ptgs2tm1Jed/J (COX-2-/-) mice were purchased from The Jackson Laboratory. C57BL/6 Ptger2tm1Sna (EP-2-/-) mice were a gift form Dr. Shu Narumiya, (Faculty of Medicine, University of Kyoto). Wild type B6/129S (COX-2+/+) and C57BL/6 (EP-2+/+) mice were obtained by breeding heterozygote pairs.
In vivo infections were performed with Y T. cruzi strain as described [6, 7]. Groups of 3–15 mice were infected with 2,000 trypomastigotes per mice by intraperitoneal injection. Groups of 3–6 non-infected mice were included in the experiments as a control. Survival was monitored daily and parasitemia levels were checked every 2–3 days. Mice blood and tissues were collected at 0 (non-infected), 14 and 21 days post-infection (d.p.i.), as indicated.
This study was carried out in strict accordance with the European Commission legislation for the protection of animals used for scientific purposes (Directives 86/609/EEC and 2010/63/EU). Mice were maintained under pathogen-free conditions at the Centro de Biología Molecular Severo Ochoa (CSIC-UAM) animal facility. The protocol for the treatment of the animals was approved by the ‘‘Comité de Ética de Investigación de la Universidad Autónoma de Madrid”, Spain (permits CEI-14-283 and CEI-47-899). Animals had unlimited access to food and water. They were euthanized in a CO2 chamber and all efforts were made to minimize their suffering.
Hearts were perfused with Phosphate buffered saline (PBS) solution containing 1UI/ml of heparin, minced into small pieces with a sterile scalpel and DNA was isolated with High PurePCR Template preparation Kit (Roche). For T. cruzi detection, we used the quantitative PCR (qPCR) assay described by Piron et al. . 100, 10, 1, 0.1 and 0.01 pg of DNA purified from Y strain epimastigotes were used to generate the standard curve. qPCR reactions were performed with 100 ng of genomic DNA and murine Tnf gene primers were used as DNA loading control.
mRNA analysis by quantitative RT-PCR
For RNA extraction, heart tissue was perfused with PBS containing 1UI/ml of heparin, cut in small pieces using a sterile scalpel blade, followed by mechanical disruption using a PT 1300 D homogenizer (Kinematica Polytron, Fisher Scientific) in TRIzol reagent (Invitrogen) as indicated by the manufacturer. Gene expression was analyzed by quantitative reverse transcription PCR (qRT-PCR). Reverse transcription of total RNA was performed using the components of the High Capacity cDNA Archive Kit (Applied Biosystems. Life Sciences) or the SuperScript Enzyme (Invitrogen, Life Sciences). Amplification were performed using TaqMan MGB probes (S1 Table) and the TaqMan Universal PCR Master Mix (Applied Biosystems) on an ABI PRISM 7900 HT instrument (Applied Biosystems. Life Sciences). For cultured cells, samples were treated as mentioned above except for the mechanical disruption. All samples were assayed in triplicate. Quantification of gene expression by real-time PCR was calculated by the comparative threshold cycle (CT) method as described in  (RQ = 2-ΔΔCT). All quantifications were normalized to the ribosomal 18S control to account for the variability in the initial concentration of RNA and in the conversion efficiency of the reverse transcription reaction.
Protein expression analysis
Protein extracts were prepared from heart tissue perfused with PBS containing 1UI/ml of heparin, cut in small pieces using a sterile scalpel blade followed by mechanical disruption in Triton X-100 based protein lysis buffer. Protein concentration was determined by the bicinchoninic acid method (BCA, Pierce) using Bovine Serum Albumin (BSA) for the standard curve. Western blot analyses were performed as follows: 15 or 50 μg of cell or tissue extract were fractionated on SDS polyacrylamide gel and transferred to a Nitrocellulose membrane Hybond-ECL (Amersham Biosciences) and blocked in 5% fat free dry milk or 5% BSA in 0,1% Tween-20 Tris Buffered Saline. Membranes were incubated overnight with diluted primary antibodies (S2 Table) at 4–8°C. The membranes were incubated with horseradish peroxidase conjugated secondary antibodies (S2 Table) and detection was carried out with Supersignal detection reagent (Pierce) followed by photographic film exposure. Fiji package software was used to quantify band intensity normalizing band areas of the sample to their respective loading control.
Cardiac tissues from mice were placed in 10% neutral buffered formalin for at least 4 hours at room temperature followed by incubation in 70% ethanol overnight. Samples were then embedded in paraffin (Tissue Embedding Station Leica EG1160), and 5 μm tissue sections were prepared (Microtome Leica RM2155). Samples were deparaffinized and rehydrated using a Tissue Processing Station Leica TP1020. Slides were stained with Masson´s Trichrome staining and mounted permanently in Eukitt´s quick hardening mounting medium (Biochemika, Fluka analytical). The sections were microscopically analyzed in a Leica microscope (DMD 108, Leica microsystems Wetzlar GmbH, Germany) using the 20x magnification objective lens and Lamp intensity 10 and f/Stop 12. Ventricular myocardium micrographs were taken avoiding pericardium, endocardium, atria and big vessels. Nine pictures of different sections, separated by at least 50 μm, per heart were taken. The degree of inflammatory-cell infiltration was quantified using the Fiji package  and the plugin Trainable Weka Segmentation developed by Ignacio Arganda Carreras (Versailles, France)  (Image J macro used for automated image analysis is detailed in S1 File) and expressed as the percentage of the nuclei/tissue area ratio.
Organs were removed from mice at different d.p.i., cut and fixed in a 4% paraformaldehyde PBS buffered solution for 2h at room temperature, followed by incubation in a 30% sucrose solution at 4°C overnight. Tissues were then embedded in Tissue-Tek OCT in Cryomolds (Sakura) and frozen. 10 μm sections were cut using a cryostat Leica CM1900. Slides were fixed in acetone for 10 min at room temperature and incubated 10 min with NH4Cl to reduce autofluorescence. Then, slides were washed with PBS, permeabilized with 0,1% Triton X-100, blocked and incubated over night at 4°C with primary antibodies (S2 Table) in blocking buffer (PBS 0,1% Triton X-100, 5% BSA). The samples were washed with PBS and secondary antibodies (S2 Table) were added in blocking buffer and incubated overnight at 4°C. Blocking of unspecific secondary antibody binding was achieved by addition of 2% of normal serum of the species in which the secondary antibody was raised. As a negative control, sections were treated in the same manner, except that incubation with primary antibody was omitted. Nuclei were stained using 1 μg/ml of DAPI (268298, Merck). Prolong Gold Antifade Reagent (Invitrogen) was used to mount the slides that were kept at 4°C until observation. Stained slides were observed with the confocal laser scanning microscope LSM710, coupled to an AxioimagerM2 microscope (Zeiss). The micrographs were processed using the software ZEN (Zeiss) or the Fiji Package.
Isolation of Ly6G+ and CD11b+Ly6G- cells by magnetic sorting
BALB/c (n = 15) or C57BL/6 mice (n = 15) were infected i.p. with 2,000 trypomastigotes of the Y strain. At 21 d.p.i. for BALB/c and 14 d.p.i. for C57BL/6, mice were euthanized in a CO2 chamber and hearts were aseptically removed, perfused with 10 ml PBS containing 1UI/ml of heparin, and kept in cold Hank´s balanced saline solution (HBSS). Then, hearts were pooled in a cell culture dish, washed thoroughly with HBSS and minced into small pieces with a sterile surgery blade. Mouse hearts (maximum 4 per tube) were transferred into the gentleMACS C tube containing 4,7 mL of HBSS. 300μL of Collagenase II solution (600 U/ml) and 10 μl DNase I solution (60U/ml) were added. Then tissue was disrupted with GentleMACS Dissociator (Miltenyi Biotec GMbH). To obtain cell suspensions, a 70 μm cell strainer (Falcon BD) was used. After red blood cells lysis, the cells were magnetically sorted. For Ly6G+ cell sorting, anti Ly-6G MicroBead kit was used with MACS LS columns and MACS Separators (Miltenyi Biotec GmbH), following manufacturer instructions. Ly6G- fraction of the cell suspension was afterwards processed for CD11b+ cell sorting using CD11b Microbeads kit.
Analysis of prostanoids
Prostanoid levels were determined in mouse tissue extracts from 0 (non-infected) and 21 d.p.i. by Metabolon Inc., and expressed as ScaledImpData as previously described . To determine in vitro prostanoid production, heart infiltrating cells were magnetically sorted as described above and incubated 30 minutes at 37°C in 500 μl of RPMI without Fetal bovine serum (FBS) in the presence of 25 μM [14C] AA, PerkinElmer (Massachusetts, USA). 500 μl of 2% acetic acid in cold methanol was added to extract and preserve AA derivatives. Samples were vortexed and the air inside the tube was substituted by inert nitrogen gas. Samples were kept frozen at -80°C until HPLC was performed. HPLC device was composed by a Beckman Solvent Module 126 with the column Ultraphere ODS (C-18, Beckman-Coulter) 5 μm diameter sphere particle, 4.5 mm and 25 cm column diameter and length respectively and a Beckman 171 Radioisotope Detector. Scintillation liquid Ecoscint H was purchased from National Diagnostics. Prostanoids were resolved with the isocratic flow (1ml/min) of the mobile phase: Acetonitrile/water/acetic acid 33:67:0.1 v/v/v. Standards were produced using [14C] Arachidonic Acid and different cell types expressing the respective enzymes, and [14C] Arachidonic Acid incubated in medium was used as input control as described .
For in vivo experiments, data are shown as means ± SEM. All the in vitro experiments were performed at least three times. Significance was evaluated by Student’s t-test when two groups were compared. ANOVA one way followed by Tukey post-test was used when groups of samples from an experiment had different time points. ANOVA two way followed by Bonferroni post-test were used when the experiment included time and mice strain as variables. For survival analysis, we used Gehan-Breslow-Wilcoxon method. GraphPad Prism 5.00 software (La Jolla, CA, USA) was used for statistical analysis.
In order to clarify the role of prostanoids in the outcome of T. cruzi infection we first analyzed the expression of prostanoid-synthesizing enzymes in cardiac tissue from T. cruzi susceptible (BALB/c) and non-susceptible (C57BL/6) mice. Our results showed an increase of COX-2/mPGES-1/PGE2 axis in heart tissue upon infection in both strains of mice, indicating that it has no direct effect on susceptibility to infection. Confocal microscopy analysis showed the presence of CD68+Arg-1+COX-2- cells and CD68+Arg-1-COX-2+, suggesting that there are at least two subpopulations of monocytic infiltrating cells with mutually exclusive expression of those enzymes. Thus, our results show that the myeloid population infiltrating the heart in T. cruzi infection is more complex than previously described , and suggests a difference in the function of these two myeloid populations. Macrophages can rapidly change their phenotype and function in response to local microenvironmental signals, playing key roles in the initiation and resolution of inflammation and tissue homeostasis  and could be involved in tissue repair and fibrosis . Thus, myeloid cardiac infiltration could inhibit parasite replication and also facilitate the repair of damaged muscular tissue . A suggestive hypothesis is that COX-2 expressing macrophages could be linked to inflammation meanwhile Arg-1+ macrophages could be involved in tissue repair.
Immunostaining of heart tissue sections showed the presence of myeloid and non-myeloid cells positive for COX-2 in heart tissue sections of both BALB/c and C57BL/6 mice. However, after purification of myeloid cells from heart tissue, we found that only a particular subset expressed COX-2, being the levels of COX-2 expression higher in C57BL/6 than BALB/c mice. Likely, non-myeloid COX-2 positive cells are lost in the purification process, a fact that might account for the apparent contrary results.
Interestingly, we demonstrated that PGE2 and 6-oxo-PGF1α (stable hydrolysis product of PGI2) were elevated in infected heart tissue. Furthermore, monocytes (CD11b+Ly6G-) isolated from infected heart express COX-2, and are able to produce high levels of PGE2 ex vivo. The differences in metabolites detected in total heart extracts versus purified myeloid cells are likely due to their synthesis by other cell types and/or enrichment after cell purification. In agreement with this, we have previously reported that T. cruzi infection induces COX-2 in cardiomyocytes, leading to PGF2α and TXA2 production . Although COX-2 expression can be induced in CD4+ T cells upon activation , heart infiltrating CD4+ cells did not express detectable levels of COX-2.
On the other hand, the increase of Tbxas1 and Hpgds gene expression observed upon T. cruzi infection in both C57BL/6 and BALB/c mice suggests the production of their respective TXA2 and PGD2 metabolites in infected cardiac tissue. Tbxas1 was elevated up to 28 d.p.i. and its product, TXA2, besides its vascular functions , could have a pro-inflammatory role for monocytes . In contrast, Hpgds expression showed a gradual increase during the acute phase, and its product, PGD2, could be involved in resolution of inflammation, as described in other settings [48–50]. Resistant C57BL/6 mice showed significantly higher expression of Hpgds at 21 d.p.i. and lower expression of Tbxas1 at 28 d.p.i. than the susceptible BALB/c mice, suggesting that C57BL/6 may resolve inflammation earlier than BALB/c infected mice. However, TXA2 and PGD2 metabolites were not detected in purified Ly6G+ nor in CD11b+Ly6G- cells, suggesting that they could be produced by other infiltrating cell types or by infected cardiomyocytes .
Previous reports using COX-2 inhibitors in T. cruzi infection showed discordant results . Moreover, COX-2 inhibitors may interfere with the immune response , but more importantly, many COX-2 inhibitors have effects independent of their ability to inhibit cyclooxygenase activity [51–53]. For those reasons, we analyzed the contribution of COX-2 by using a mouse model deficient for its expression. We found a small variation in parasitemia (30% reduction at the peak of parasitemia) in COX-2-/- respect to the COX-2+/+ mice, which cannot be taken as indicative of resistance. In addition, no changes were observed in cardiac parasite burden, in spite that COX-2-/- mice expressed less iNOS than COX-2+/+ mice, considered to be key for resistance in T. cruzi infection , indicating that heart parasite load is not affected by the lack of COX-2 expression. Interestingly, we found that COX-2 was required for leukocyte infiltration and inflammation in the heart upon T. cruzi infection, but it did not affect systemic inflammation. However, COX-2-/- mice are resistant to death in sepsis, indicating that in this case COX-2 has a systemic pro-inflammatory role . An important role of endogenous COX-2 derived PGs in migration of immune cells to infected tissues or lymphoid organs is becoming evident . Thus, the decrease in cardiac inflammation and in local production of cytokines and chemokines observed in COX-2-/- infected mice, indicate a pro-inflammatory role of prostanoids as PGE2 in acute myocarditis.
We have previously described that PGE2 induces COX-2 and mPGES-1 expression in an autocrine loop required for full activation of macrophages . Thus, the fact that COX-2-/- mice showed a reduced Ptges mRNA expression (mPGES-1) suggest a blockade of the autocrine loop that may impair full activation of macrophages, resulting in the reduced cardiac infiltration observed. In the same direction, lack of PGE2 signaling through EP-2 receptor in EP-2-/- infected mice, resulted in reduced Ptgs (COX-2) mRNA expression that may also block the autocrine loop, impairing macrophages to infiltrate the cardiac tissue. This is in agreement with the observed decrease in Ccl2 mRNA expression in COX-2-/- and EP-2-/- infected mice respect to wild type infected mice, since this chemokine is required for migration of monocytes to the inflamed infected tissue . Moreover, PGE2 also affects migration of myeloid cells potentiating CCL2 activity . Therefore, the reduction of cardiac infiltration in both animal models suggest a detrimental pro-inflammatory role of COX-2 in the onset of cardiac inflammation.
Strikingly, Arg-1 and iNOS expression, markers of MDSCs, was higher in hearts of infected EP-2-/- mice than in those from COX-2-/- infected mice hearts, indicating that infiltrating cells from EP-2-/- mice present a more marked MDSCs phenotype. In addition, the effect of EP-2 deficiency on cytokine and chemokine production in heart, was milder than the observed in COX-2-/- infected mice. In the hearts of C57BL/6 mice, infection caused a greater significant increase in the expression of Ptger2, which validates the use of EP-2-/- mice in the C57BL/6 background. But still Ptger1 and Ptger4 were significantly increased although in a minor extent. Thus in EP-2-/- infected mice PGE2 can still signal through Ptger1 and Ptger4 causing this milder effect in EP-2-/- mice in comparison to the observed in COX-2-/- infected hearts. In contrast, in COX-2-/- infected mice, mPGES1 synthase expression is substantially reduced and PGH2 substrate for PGE2 production likely relies on constitutive COX-1 activity. Thus, the decreased levels of PGE2 may affect signaling through all PGE2 receptors, having a broader effect on leukocyte infiltration. The response to T. cruzi infection in mice deficient in other enzymes and products of the AA pathway has been scarcely studied [26, 27]. Sharma et al. described that deficiency of iPLA2-γ (Ca++ independent PLA2 isoform-γ), which is involved in AA membrane release, aggravated infection and decreased survival, while Mukherjee et al. described that COX-1-/- mice showed higher parasitemia than wild type infected mice, but no difference in survival was noted . In our hands, interference within the AA pathway at a different level, as COX-2 mediated production of prostanoids or PGE2/EP-2 signaling, results in decreased inflammation in heart of T. cruzi infected mice, with low incidence in parasite burden and survival. Altogether, these results point to an essential role of the AA pathway in heart inflammation during T. cruzi infection.
In the other hand, related with the prostanoid pathway, 5-lipoxygenase (5-LO) has been shown to play a detrimental role during T. cruzi infection by potentiating heart parasitism and inflammation [57, 58] through the regulation of iNOS activity . However, further studies are needed to elucidate the crosstalk between LO and COX pathways during infection.”
Besides, we have previously showed that monocytic CD11b+Ly6G- heart infiltrating cells (MDSCs), expressing iNOS and Arg-1 suppressed ex vivo T cell proliferation . Since some of these infiltrating cells also express COX-2 and produce PGE2 it is possible that COX-2-derived PGs could contribute to immune suppression, a possibility that should be addressed in the future.
In conclusion, during acute T. cruzi infection there is an increase in the expression of many enzymes of the AA metabolism, including COX-2 and mPGES-1 that leads to an increase in their metabolite PGE2, partially due to infiltrating myeloid cells in the heart. Besides, we have identified a new myeloid infiltrating population characterized by the expression of COX-2. Thus, so far there are at least three different myeloid populations infiltrating the T. cruzi infected heart: granulocytes, monocytic MDSCs expressing iNOS and Arg-1 and monocytic cells expressing COX-2. COX-2 activity likely increases PGE2 levels in heart tissue, which play a pro-inflammatory role by signaling through EP-2. However, the phenotype of EP-2-/- is not as strong as COX-2-/- infected mice probably due to PGE2 signaling through alternative EP receptors. Our findings suggest that COX-2 plays a detrimental role in acute Chagas disease myocarditis. Further research of the AA pathway is needed to completely understand its role during T. cruzi infection for immune intervention approaches.
S1 Fig. Survival, parasite burden and inflammation of BALB/c and C57BL/6 mice infected with T. cruzi.
(A) Survival was checked every day during the infection in BALB/c and C57BL/6 mice (n = 5). (B) The presence of the parasites in the blood of BALB/c and C57BL/6 mice was quantified by direct counting under optical microscopy. Means ± SEM of a representative experiment (n = 4) from two independent experiments are shown. (* p< 0.05; ** p< 0.01). (C) Histology of cardiac tissue in non-infected (0 d.p.i.) or 21 d.p.i T. cruzi infected BALB/c and C57BL/6 mice. Representative pictures of heart tissue sections of each group, processed for Masson`s Trichrome histology staining, are shown. Black arrows point to the infiltrating leukocytes and red arrows point to parasite nests. Scale bar is 100 μm.
S2 Fig. COX-2 and CD4 expression in T. cruzi infected mouse cardiac tissue.
(A) Heart tissue was isolated at 14 d.p.i. from infected C57BL/6 mice and sections were stained with DAPI for nuclei (Blue), the lymphocyte marker CD4 (green) or COX-2 (red). A representative picture of several sections analyzed in at least three different mice from two independent experiments is shown. (B) Control sample from heart of C57BL/6 mice at 14 d.p.i. incubated with secondary antibodies coupled to Alexa Fluor (AF) 488, and 647 in the absence of primary antibodies. (C) Same as in A from heart of BALB/c mice at 21 d.p.i.. (D) Same as in B from heart of BALB/c mice at 21 d.p.i. (E) Control samples from heart of BALB/c mice at 21 d.p.i. incubated with secondary antibodies coupled to Alexa Fluor (AF) 488, 555 and 647 in the absence of primary antibodies. Scale bar is 20 μm.
S3 Fig. Serum levels of TNFα in COX-2+/+, COX-2-/-, EP-2+/+ and EP-2-/- mice during T. cruzi infection.
TNFα concentration in non-infected mice (0 d.p.i.) and at 14 d.p.i. in blood serum of (A) COX-2+/+ and COX-2-/- and (B) EP-2+/+ and EP-2-/- mice. Representative means ± SEM from two independent experiments are shown (n = 6) (ns = non-significant).
S4 Fig. Comparison of the gene expression of cell markers, chemokines, cytokines and inflammatory enzymes basal levels in the heart of COX-2+/+ and COX-2-/- mice.
mRNA levels of the different genes analyzed was determined by qRT-PCR in heart tissue RNA samples isolated from non-infected (0 d.p.i.) COX-2+/+ or COX-2-/- mice. Data are expressed as RQ calculated from CT values as described in Methods. Gene expression of lymphoid and myeloid cell markers as Ptprc, Cd4, Cd8a, Cd68 and Itgax (A), chemokines as Ccl2, Ccl5 and Cxcl9 (B), cytokines as Ifng, Tnf, Il4, Il6 and Il10 (C) and enzymes as Arg1, Nos2, Ptgs1 and Ptges (mPGES1) (D) is shown. Means ± SEM from one representative experiment (n = 3) out of four is shown (n = 5; * p<0.05).
S5 Fig. Comparison of the gene expression of cell markers, chemokines, cytokines and inflammatory enzymes basal levels in the heart of EP-2+/+ and EP-2-/- mice.
mRNA levels of the different genes analyzed was determined by qRT-PCR in heart tissue RNA samples isolated from non-infected (0 d.p.i.) EP-2+/+ or EP-2-/- mice. Data are expressed as RQ calculated from CT values as described in Methods. Gene expression of lymphoid and myeloid cell markers as Ptprc, Cd4, Cd8a, Cd68 and Itgax (A), chemokines as Ccl2, Ccl5 and Cxcl9 (B), cytokines as Ifng, Tnf, Il4, Il6 and Il10 (C) and enzymes as Nos2, Ptgs2 and Arg1 (D) is shown. Means ± SEM from one representative experiment (n = 3) out of four is shown (n = 5; * p<0.05).
S1 Table. Taqman probes.
List of the Taqman Probes from Applied Biosystems (A&B) used in the mRNA analysis by quantitative RT-PCR, including reference of the manufacturer, gene symbol and protein name.
S2 Table. Antibodies.
List of antibodies from different providers used in confocal immunofluorescence and western blot analysis including the reference from each provider, the application and the dilution utilized.
S1 File. Image J macro used for automated image analysis.
Plugin Trainable Weka Segmentation developed by Ignacio Arganda Carreras (Versailles, France).
The authors would like to thank Beatriz Barrocal for taking care of the animals and Maria A. Chorro and Maria C. Maza for their excellent technical assistance. We thank Dr. Alejandro Pascual and Dr. Laura García-Bermejo from the Ramón y Cajal Hospital for their precious help with the histologic analysis. We also thank the personal of the Confocal Microscopy Service (S.M.O.C.) at the CBMSO for their excellent assistance.
Conceived and designed the experiments: NAG NG MF MAÍ. Performed the experiments: NAG NG HC MC CCM CP. Analyzed the data: NAG NG MF. Contributed reagents/materials/analysis tools: MC LV. Wrote the paper: NAG MC MAÍ NG MF.
- 1. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, et al. Control of neglected tropical diseases. The New England journal of medicine. 2007;357(10):1018–27. pmid:17804846.
- 2. Morillo CA. Infection with Trypanosoma cruzi and progression to cardiomyopathy: what is the evidence and is the tide finally turning? Circulation. 2013;127(10):1095–7. doi: 10.1161/CIRCULATIONAHA.113.000891 pmid:23393009.
- 3. Moncayo A, Silveira AC. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Memorias do Instituto Oswaldo Cruz. 2009;104 (Suppl 1):17–30. pmid:19753454.
- 4. Rodriguez HO, Guerrero NA, Fortes A, Santi-Rocca J, Girones N, Fresno M. Trypanosoma cruzi strains cause different myocarditis patterns in infected mice. Acta Trop. 2014;139:57–66. Epub 2014/07/16. doi: 10.1016/j.actatropica.2014.07.005 S0001-706X(14)00227-7 [pii]. pmid:25017312.
- 5. Molina HA, Kierszenbaum F. Kinetics of development of inflammatory lesions in myocardial and skeletal muscle in experimental Trypanosoma cruzi infection. J Parasitol. 1988;74(3):370–4. Epub 1988/06/01. pmid:3132546.
- 6. Cuervo H, Pineda MA, Aoki MP, Gea S, Fresno M, Girones N. Inducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68+ macrophages. The Journal of infectious diseases. 2008;197(12):1772–82. pmid:18473687. doi: 10.1086/529527.
- 7. Cuervo H, Guerrero NA, Carbajosa S, Beschin A, De Baetselier P, Girones N, et al. Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. J Immunol. 2011;187(5):2656–65. pmid:21804013. doi: 10.4049/jimmunol.1002928.
- 8. Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol. 2008;9(2):162–76. Epub 2008/01/25. doi: 10.1038/nrm2335 nrm2335 [pii]. pmid:18216772.
- 9. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, et al. Cyclooxygenase in biology and disease. Faseb J. 1998;12(12):1063–73. pmid:9737710.
- 10. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends in immunology. 2002;23(3):144–50. pmid:11864843.
- 11. Carey MA, Bradbury JA, Seubert JM, Langenbach R, Zeldin DC, Germolec DR. Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. J Immunol. 2005;175(10):6878–84. pmid:16272346.
- 12. Goldmann O, Hertzen E, Hecht A, Schmidt H, Lehne S, Norrby-Teglund A, et al. Inducible cyclooxygenase released prostaglandin E2 modulates the severity of infection caused by Streptococcus pyogenes. J Immunol. 2010;185(4):2372–81. pmid:20644176. doi: 10.4049/jimmunol.1000838.
- 13. Takahashi T, Zhu SJ, Sumino H, Saegusa S, Nakahashi T, Iwai K, et al. Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis. Life sciences. 2005;78(2):195–204. pmid:16107267.
- 14. Krause P, Bruckner M, Uermosi C, Singer E, Groettrup M, Legler DF. Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells. Blood. 2009;113(11):2451–60. pmid:19029446. doi: 10.1182/blood-2008-05-157123.
- 15. van der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. The Journal of experimental medicine. 1995;181(2):775–9. pmid:7836930.
- 16. Aronoff DM, Canetti C, Peters-Golden M. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J Immunol. 2004;173(1):559–65. pmid:15210817.
- 17. Weinberg DA, Weston LK, Kaplan JE. Influence of prostaglandin I2 on fibronectin-mediated phagocytosis in vivo and in vitro. Journal of leukocyte biology. 1985;37(2):151–9. pmid:2981944.
- 18. Panzer U, Uguccioni M. Prostaglandin E2 modulates the functional responsiveness of human monocytes to chemokines. European journal of immunology. 2004;34(12):3682–9. pmid:15484190.
- 19. Diaz-Munoz MD, Osma-Garcia IC, Iniguez MA, Fresno M. Cyclooxygenase-2 deficiency in macrophages leads to defective p110gamma PI3K signaling and impairs cell adhesion and migration. J Immunol. 2013;191(1):395–406. Epub 2013/06/05. doi: 10.4049/jimmunol.1202002 jimmunol.1202002 [pii]. pmid:23733875.
- 20. de Barros-Mazon S, Guariento ME, da Silva CA, Coffman RL, Abrahamsohn IA. Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas disease. Clinical immunology (Orlando, Fla. 2004;111(1):137–45. pmid:15093563.
- 21. Sousa AS, Xavier SS, Freitas GR, Hasslocher-Moreno A. Prevention strategies of cardioembolic ischemic stroke in Chagas' disease. Arquivos brasileiros de cardiologia. 2008;91(5):306–10. pmid:19142374.
- 22. Gomes JA, Molica AM, Keesen TS, Morato MJ, de Araujo FF, Fares RC, et al. Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease. Hum Immunol. 2014;75(1):20–8. Epub 2013/09/28. doi: 10.1016/j.humimm.2013.09.009 S0198-8859(13)00530-2 [pii]. pmid:24071371.
- 23. Cardoni RL, Antunez MI. Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections. Mediators of inflammation. 2004;13(4):235–40. pmid:15545053.
- 24. Celentano AM, Gorelik G, Solana ME, Sterin-Borda L, Borda E, Gonzalez Cappa SM. PGE2 involvement in experimental infection with Trypanosoma cruzi subpopulations. Prostaglandins. 1995;49(3):141–53. pmid:7652183.
- 25. D'Avila H, Freire-de-Lima CG, Roque NR, Teixeira L, Barja-Fidalgo C, Silva AR, et al. Host cell lipid bodies triggered by Trypanosoma cruzi infection and enhanced by the uptake of apoptotic cells are associated with prostaglandin E(2) generation and increased parasite growth. The Journal of infectious diseases. 2011;204(6):951–61. pmid:21849292. doi: 10.1093/infdis/jir432.
- 26. Sharma J, Eickhoff CS, Hoft DF, Ford DA, Gross RW, McHowat J. The absence of myocardial calcium-independent phospholipase A2gamma results in impaired prostaglandin E2 production and decreased survival in mice with acute Trypanosoma cruzi infection. Infect Immun. 2013;81(7):2278–87. Epub 2013/02/23. doi: 10.1128/IAI.00497-12 IAI.00497-12 [pii]. pmid:23429536; PubMed Central PMCID: PMC3697611.
- 27. Mukherjee S, Machado FS, Huang H, Oz HS, Jelicks LA, Prado CM, et al. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease. PloS one. 2011;6(2):e16959. pmid:21347238. doi: 10.1371/journal.pone.0016959.
- 28. Freire-de-Lima CG, Nascimento DO, Soares MB, Bozza PT, Castro-Faria-Neto HC, de Mello FG, et al. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature. 2000;403(6766):199–203. pmid:10646605.
- 29. Hideko Tatakihara VL, Cecchini R, Borges CL, Malvezi AD, Graca-de Souza VK, Yamada-Ogatta SF, et al. Effects of cyclooxygenase inhibitors on parasite burden, anemia and oxidative stress in murine Trypanosoma cruzi infection. FEMS immunology and medical microbiology. 2008;52(1):47–58. pmid:18031539.
- 30. Machado FS, Mukherjee S, Weiss LM, Tanowitz HB, Ashton AW. Bioactive lipids in Trypanosoma cruzi infection. Advances in parasitology. 2011;76:1–31. pmid:21884885. doi: 10.1016/B978-0-12-385895-5.00001-3.
- 31. Kuroda E, Yamashita U. Mechanisms of enhanced macrophage-mediated prostaglandin E2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice. J Immunol. 2003;170(2):757–64. pmid:12517938.
- 32. Roggero E, Perez A, Tamae-Kakazu M, Piazzon I, Nepomnaschy I, Wietzerbin J, et al. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities. Clinical and experimental immunology. 2002;128(3):421–8. pmid:12067296.
- 33. Sanoja C, Carbajosa S, Fresno M, Girones N. Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infection. PloS one. 2013;8(6):e65820. Epub 2013/06/19. doi: 10.1371/journal.pone.0065820 PONE-D-13-02620 [pii]. pmid:23776551; PubMed Central PMCID: PMC3679147.
- 34. Iniguez MA, Punzon C, Fresno M. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. J Immunol. 1999;163(1):111–9. pmid:10384106.
- 35. Narumiya S. Prostanoids and inflammation: a new concept arising from receptor knockout mice. Journal of molecular medicine (Berlin, Germany). 2009;87(10):1015–22. pmid:19609495.
- 36. Diaz-Munoz MD, Osma-Garcia IC, Fresno M, Iniguez MA. Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages. Biochem J. 2012;443(2):451–61. Epub 2012/01/25. doi: BJ20111052 [pii] doi: 10.1042/BJ20111052 pmid:22268508.
- 37. Piron M, Fisa R, Casamitjana N, Lopez-Chejade P, Puig L, Verges M, et al. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop. 2007;103(3):195–200. pmid:17662227.
- 38. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–8. Epub 2008/06/13. pmid:18546601.
- 39. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nature methods. 2012;9(7):676–82. pmid:22743772. doi: 10.1038/nmeth.2019.
- 40. Girones N, Carbajosa S, Guerrero NA, Poveda C, Chillon-Marinas C, Fresno M. Global Metabolomic Profiling of Acute Myocarditis Caused by Trypanosoma cruzi Infection. PLoS Negl Trop Dis. 2014;8(11):e3337. Epub 2014/11/21. doi: 10.1371/journal.pntd.0003337 PNTD-D-14-01266 [pii]. pmid:25412247.
- 41. Sola J, Godessart N, Vila L, Puig L, de Moragas JM. Epidermal cell-polymorphonuclear leukocyte cooperation in the formation of leukotriene B4 by transcellular biosynthesis. J Invest Dermatol. 1992;98(3):333–9. Epub 1992/03/01. pmid:1312107.
- 42. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nature reviews. 2011;11(11):723–37. pmid:21997792. doi: 10.1038/nri3073.
- 43. Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Seminars in liver disease. 2010;30(3):245–57. pmid:20665377. doi: 10.1055/s-0030-1255354.
- 44. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. The Journal of experimental medicine. 2007;204(5):1057–69. pmid:17485518.
- 45. Corral RS, Guerrero NA, Cuervo H, Girones N, Fresno M. Trypanosoma cruzi Infection and Endothelin-1 Cooperatively Activate Pathogenic Inflammatory Pathways in Cardiomyocytes. PLoS Negl Trop Dis. 2013;7(2):e2034. pmid:23409199. doi: 10.1371/journal.pntd.0002034.
- 46. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science (New York, NY. 2002;296(5567):539–41. pmid:11964481.
- 47. Caughey GE, Pouliot M, Cleland LG, James MJ. Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes. J Immunol. 1997;158(1):351–8. pmid:8977210.
- 48. Bellows CF, Alder A, Wludyka P, Jaffe BM. Modulation of macrophage nitric oxide production by prostaglandin D2. The Journal of surgical research. 2006;132(1):92–7. pmid:16289592.
- 49. Kanaoka Y, Urade Y. Hematopoietic prostaglandin D synthase. Prostaglandins, leukotrienes, and essential fatty acids. 2003;69(2–3):163–7. pmid:12895599.
- 50. Rajakariar R, Hilliard M, Lawrence T, Trivedi S, Colville-Nash P, Bellingan G, et al. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(52):20979–84. doi: 10.1073/pnas.0707394104 pmid:18077391; PubMed Central PMCID: PMC2409252.
- 51. Schror K. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer. Best Pract Res Clin Gastroenterol. 2011;25(4–5):473–84. Epub 2011/11/30. doi: 10.1016/j.bpg.2011.10.016 S1521-6918(11)00104-1 [pii]. pmid:22122764.
- 52. Iniguez MA, Punzon C, Cacheiro-Llaguno C, Diaz-Munoz MD, Duque J, Cuberes R, et al. Cyclooxygenase-independent inhibitory effects on T cell activation of novel 4,5-dihydro-3 trifluoromethyl pyrazole cyclooxygenase-2 inhibitors. Int Immunopharmacol. 2010;10(10):1295–304. Epub 2010/08/17. doi: 10.1016/j.intimp.2010.07.013 S1567-5769(10)00240-7 [pii]. pmid:20709632.
- 53. Xu H, Izon DJ, Loftin C, Spain LM. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition. Cell Immunol. 2001;214(2):184–93. Epub 2002/06/29. doi: S0008-8749(01)91891-X [pii] doi: 10.1006/cimm.2001.1891 pmid:12088417.
- 54. Holscher C, Kohler G, Muller U, Mossmann H, Schaub GA, Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun. 1998;66(3):1208–15. pmid:9488415; PubMed Central PMCID: PMC108035.
- 55. Ejima K, Layne MD, Carvajal IM, Kritek PA, Baron RM, Chen YH, et al. Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death. Faseb J. 2003;17(10):1325–7. pmid:12738799.
- 56. Paiva CN, Figueiredo RT, Kroll-Palhares K, Silva AA, Silverio JC, Gibaldi D, et al. CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear activation during acute Trypanosoma cruzi infection. Journal of leukocyte biology. 2009;86(5):1239–46. pmid:19641038. doi: 10.1189/jlb.0309187.
- 57. Borges CL, Cecchini R, Tatakihara VL, Malvezi AD, Yamada-Ogatta SF, Rizzo LV, et al. 5-Lipoxygenase plays a role in the control of parasite burden and contributes to oxidative damage of erythrocytes in murine Chagas' disease. Immunol Lett. 2009;123(1):38–45. doi: 10.1016/j.imlet.2009.02.002 pmid:19428550.
- 58. Pavanelli WR, Gutierrez FR, Mariano FS, Prado CM, Ferreira BR, Teixeira MM, et al. 5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. Microbes Infect. 2010;12(8–9):587–97. doi: 10.1016/j.micinf.2010.03.016 pmid:20381637.
- 59. Panis C, Mazzuco TL, Costa CZ, Victorino VJ, Tatakihara VL, Yamauchi LM, et al. Trypanosoma cruzi: effect of the absence of 5-lipoxygenase (5-LO)-derived leukotrienes on levels of cytokines, nitric oxide and iNOS expression in cardiac tissue in the acute phase of infection in mice. Experimental parasitology. 2011;127(1):58–65. doi: 10.1016/j.exppara.2010.06.030 pmid:20599987.